Cannabis Science Has US Federal Government Clearance that Changes the Industry, Access to Federal Government …

IRVINE, CA, Jan. 05, 2018 (GLOBE NEWSWIRE) — Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce its support for the U.S. Federal Government, and the Company intends to step in with its experts to assist the Federal Government. The Company is looking to establish new Federal marijuana policy and calls on Department of Justice (DOJ) to help establish a properly-regulated Federal Policy for all patients’ safe access to pharmaceutical and pharmacy dispensed cannabinoids for various critical ailments.

Cannabis Science has launched several initiatives to study the use of cannabinoid-based medicines. For one such initiative, initial results on using nanoparticle drones to target and successfully kill stage four lung cancer cells with radiosensitizers and cannabinoids have been published in the cancer research journal “Frontiers in Oncology”.

The article can be viewed at ... read more at: http://www.nasdaq.com/press-release/cannabis-science-has-us-federal-government-clearance-that-changes-the-industry-access-to-federal-20180105-00232

by

Leave a Reply

Your email address will not be published. Required fields are marked *